QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cormedix-files-for-offering-of-up-to-63m-shares-of-common-stock-by-selling-securityholders

https://www.sec.gov/Archives/edgar/data/1410098/000121390025094067/ea0258874-s3_cormedix.htm

 cormedix-completes-enrollment-in-phase-iii-respect-trial-for-rezzayo-in-fungal-infection-prevention

- Enrollment Completed in Ongoing Phase III ReSPECT Study in Prophylaxis of Fungal Infections in Adult Patients Undergoing Allo...

 jmp-securities-reiterates-market-outperform-on-cormedix-maintains-22-price-target

JMP Securities analyst Jason N. Butler reiterates Cormedix (NASDAQ:CRMD) with a Market Outperform and maintains $22 price ta...

 cormedix-names-susan-blum-cfo-of-melinta-therapeutics-as-evp--chief-financial-officer

Planned Senior LeadershipThe following executives will form the core of the senior leadership team of the newly merged company ...

 cormedix-revised-guidance-of-pro-forma-2025-combined-revenues-to-325m-350m-vs-consensus-of-21514m-melinta-therapeutics-deal-expected-to-be-near-term-accretive-to-eps-with-double-digit-accretion-expected-in-2026

Transaction expected to be near-term accretive to EPS with double-digit accretion expected in 2026; annual run-rate synergies e...

 hedge-fund-elliott-managements-q2-moves-include-positions-tied-to-sp-500-nasdaq-nvidia-corrected

Hedge fund Elliott Management revealed a Q2 portfolio reshuffle, adding new positions tied to major indexes and tech leaders li...

 deal-dispatch-performance-food-group-and-claires-lead-a-week-of-big-auctions-retail-woes

Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid ret...

 hc-wainwright--co-maintains-buy-on-cormedix-lowers-price-target-to-17

HC Wainwright & Co. analyst Brandon Folkes maintains Cormedix (NASDAQ:CRMD) with a Buy and lowers the price target from ...

 somnigroup-internationals-cormedix-to-acquire-melinta-in-300m-deal-expanding-infectious-disease-portfolio

CorMedix Inc. ("CorMedix") (NASDAQ:CRMD), a biopharmaceutical company focused on developing and commercializing therape...

 cormedix-analyst-says-investors-could-be-further-rewarded

CorMedix boosts Q2 sales forecast as a major dialysis client accelerates DefenCath use, prompting positive analyst coverage and...

 d-boral-capital-downgrades-cormedix-to-hold

D. Boral Capital analyst Jason Kolbert downgrades Cormedix (NASDAQ:CRMD) from Buy to Hold.

 hc-wainwright--co-initiates-coverage-on-cormedix-with-buy-rating-announces-price-target-of-20

HC Wainwright & Co. analyst Brandon Folkes initiates coverage on Cormedix (NASDAQ:CRMD) with a Buy rating and announces ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION